What clinicians should know about the QT interval.

By S. Al‐Khatib, N. LaPointe, J. Kramer, Robert M. Califf. Journal of the American Medical Association (JAMA), 2003

680 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/e8cc1de4617fd81c724f155b304875a62e326ba2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). (2009, background): “Both agents have been associated with QT prolongation, predisposing to cardiac arrhythmias.(138,139) Combination therapy with erythromycin and metoclopramide did demonstrate improved GRVs, allowing for greater feeding success; however, neither hospital LOS nor mortality was different.”
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) (2009, background): “Both agents have been associated with QT prolongation, predisposing to cardiac arrhythmias (138, 139).”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “460 ms in women are suggested as a guideline for the upper limit of normal on baseline ECG evaluation.(156,157) QTc prolongation .”
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, background): “The FDA extended the warning for intravenous haloperidol in 2007 and recommended continuous electrocardiogram (ECG) monitoring in patients receiving intravenous haloperidol (Al-Khatib et al. 2003; Meyer-Massetti et al. 2010).”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, background): “guideline for the upper limit of normal on baseline ECG evaluation.(156,157) QTc prolongation .”